59
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Clinical Presentation of Tuberculosis and the Degree of Immunodeficiency in Patients with HIV Infection

Pages 387-391 | Published online: 08 Jul 2009

REFERENCES

  • Pitchenik AE, Cole C, Rusell BW, Fischl MA, Spira TJ, Snider DE. Tuberculosis, atypical mycobacteriosis and the acquired immunodeficiency syndrome among Haitian and non-Haitians patients in South Florida. Ann Intern Med 1984; 101: 641–5.
  • Sunderam G, McDonald RJ, Maniatis T, Oleske J, Kapila R, Reichman LB. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA 1986; 256: 362–6.
  • Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford GW, Chaisson RE. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 1990; 162: 8–12.
  • Di Perri G, Danzi M CH, De Checchi G, Pizzighella S, Solbiati M. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989; 23: 1502–4.
  • Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of Tuberculosis among intravenous drug user with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545–50.
  • Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, et al. Exogenous reinfection with multidrug-resistant mycobacterium tuberculosis in patients with advanced HIV Infection. N Engl J Med 1993; 328: 1137–44.
  • Pitchenik AE. Tuberculosis control and the AIDS epidemic in developing countries. Ann Med Intern 1990; 113: 89–91.
  • Centers for Disease Control. Revision of the CDC Surveillance Case Definitions for Acquired Immunodeficiency Syndrome. MMWR 1987; 36: 15–55.
  • Polk BF, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987; 316: 61–6.
  • Phillips AN, Lee CA, Elford J, Jannossy G, Timms A, Bofill M, Kernoff PB. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337: 389–92.
  • Schellekens PA, Tersmette M, Roos MTL, Keet RP, Wolf F, Coutinho RA, et al. Biphasic rate CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype. AIDS 1992; 6: 665–9.
  • Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of Tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148: 1292–7.
  • Keiper MD, Beumont M, Elshami A, Langlotz CP, Miller WT. CD4 T Lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection. Chest 1995; 107: 74–80.
  • Haas DW, Des Prez RM. Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments. Am J Med 1994; 96: 439–50.
  • Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989; 38: 236–50.
  • Antonucci G, Girardi E, Armignacco O, Salmaso S, Ippolito G, the Gruppo Italiano di Studio Tuberculosi e AIDS. Tuberculosis in HIV-infected subjects in Italy: a multicentre study. AIDS 1992; 6: 1007–13.
  • Laguna F, Adrados M, Díaz F, García Aguado C, Puente S, González Lahoz JM. AIDS and Tuberculosis in Spain. A report of 140 cases. J Infect 1991; 23: 139–44.
  • Shafer RW, Chirgwin KD, Glatt AE, Dahdouh A, Landesman SH, Suster B. HIV prevalence, immunosuppresion, and drug resistance in patients with Tuberculosis in an area endemic for AIDS. AIDS 1991; 5: 399–405.
  • Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991; 324: 289–94.
  • Modilevsky T, Sattler FR, Barnes PF. Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med 1989; 149: 2201–5.
  • Pitchenik AE, Runbinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985; 131: 393–6.
  • Perlman DC, El-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree human immunodeficiency virus-related immunosuppression. Clin Infect Dis 1997; 25: 242–6.
  • Shriner KA, Mathisen GE, Goetz MB. Comparison of mycobacterial limphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis 1992; 15: 601–5.
  • Pastores SM, Naidich DP, Aranda CP, McGuinnes G, Rom WN. Intratoracic adenopathy associated with pulmonary tuberculosis in patients with human immunodeficiency virus infection. Chest 1993; 103: 1433–7.
  • Bouza E, Martín-Scapa C, Bernaldo de Quirós JCL, Matínez-Hernández D, Menarguez J, et al. High prevalence of tuberculosis in AIDS patients in Spain. Eur J Clin Microbiol Infect Dis 1988; 7: 785–8.
  • Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991; 40: 27–32.
  • Daley ChL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment length polymorphisms. N Engl J Med 1992; 326: 231–5.
  • Tuñez Bastida MV, Golpe Gómez AL, Paniagua López J. La enfermedad tuberculosa en el área sanitaria de Santiago durante el año 1995. Arch Bronconeumol 1997; 33: Suppl 1: S32.
  • Markowitz N, Hansen NI, Wilcosky TC, Hopewell Ph C, Glassroth J, Kvale PA, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Med Intern 1993; 119: 185–93.
  • Karlsson A, Moberg L, Bratt G, Halvarsson M, von Krogh G, Morfeldt L, et al. An eleven year follow-up of delayed-type hypersensitivity testing for the identification of HIV-1 infected patients at increased risk of developing AIDS. Scand J Infect Dis 1996; 28: 125–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.